MAM
PGNX

Morse Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Morse Asset Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-15,400
Closed -$113K – 145
2017
Q3 		$113K Sell
15,400
-1,000
-6% -$7.34K 0.03% 128
2017
Q2 		$111K Hold
16,400
– – 0.04% 122
2017
Q1 		$155K Buy
+16,400
New +$155K 0.05% 132